A 67-year-old man developed a sudden onset of achromatopsia. Magnetic resonance imaging showed occipital lobe infarction. Repeated episodes of neurological deficit referable to the posterior circulation initially suggested an embolic source, but subsequently proved to be due to a coagulopathy related to a carcinoma of the bladder. This has implications for the management of patients presenting with achromatopsia, and progressive or recurrent neurological episodes, and in particular the use of anticoagulation in this situation.
Introduction
'Cerebral achromatopsia is a syndrome in which the patient loses the ability to see colours after cortical damage. This loss may be complete or partial, and it may or may not be accompanied by other visual defects'."2 We describe a case of this unusual but readily recognisable clinical syndrome, and its association with a paraneoplastic coagulopathy.
Case report
A 67-year-old man was travelling as a front seat passenger in a car when he experienced a sudden brilliant flash of white throughout his vision, followed by a kaleidoscope effect, with criss-cross lines and bright colours. The experience lasted about 20 seconds, and he was left with some fogginess of vision, and was only able to see images in black and white. Three weeks previously he had experienced an episode of weakness in the right hand, lasting for two days, but otherwise had no previous neurological symptoms. Over a period of two weeks there was some improvement in his vision, but persistence of the loss of colour vision.
Eighteen months previously he had presented with haematuria. Cystoscopy demonstrated a multifocal transitional cell carcinoma on the left wall of the bladder which was in the early invasive stage. This was being controlled by repeated cystoscopy and fulguration. He had ischaemic heart disease, with occasional angina, had coronary artery by-pass grafting four years previously, and had been taking 300 mg aspirin daily.
On examination he appeared well, with a regular pulse, blood pressure 160/100 mmHg normal heart sounds, and no carotid bruits. Neurological examination was normal, but for absent colour vision and a partial right hemianopia. Visual acuity was 6/18 bilaterally.
Two weeks after the onset of visual disturbance he developed a sudden onset of upper motor neurone weakness in the right arm and face, with reduced sensation in the right arm, following a bout of heavy coughing. Investigation at this time demonstrated normal full blood count, erythrocyte sedimentation rate, prothrombin time, serum urea and electrolytes, and glucose. Treponemal serology was negative. Chest radiograph was normal. Computed tomographic (CT) scan of the brain showed an area of presumed recent infarction involving the left occipital lobe and posterior part of the temporal lobe. Magnetic resonance (MR) scan the next day showed bilateral occipital lobe infarction, mainly below the calcarine fissure (see figures). MR angiography showed the posterior circulation to be normal, with no evidence of basilar artery thrombosis. Doppler examination of the carotid arteries showed a 30% internal carotid stenosis on the right, and 55% on the left. There was no clinical or electrocardiographic evidence of an arrhythmia, and an echocardiogram showed no evidence of a cardiac source of emboli. The interpretation of his neuropsychological assessment is that the only elements of cortical blindness present were a severe achromatopsia and a mild impairment ofacuity. In addition he had an aperceptive agnosia. The degree of impairment of his primary visual processing was insufficient to account for his poor performance on tests of visual object processing.
PROGRESS
In view of the recurrent episodes of neurological deficit, which were felt to be possibly embolic, he was started on an infusion of heparin at 10 000 units over 24 hours, with caution because of the haemorrhagic nature of the infarct, and his previous haematuria. The right arm weakness resolved over three days, with a residual mild right facial weakness. He was commenced on warfarin anticoagulation with careful control.
Two weeks later, having developed mild haematuria and having discontinued the warfarin himself, he was found wandering at night, aphasic and agitated. He had a left upper motor facial weakness, and a progressive left hemiplegia. He had complete cortical blindness, with small pupils, absent gag reflex, and brisk jaw jerk. CT scan at this stage showed extensive bilateral occipital infarction. He was again commenced on a heparin infusion, and over a Within two weeks he developed a deep vein thrombosis of the right leg, with gangrenous areas in the toes, and as there was some recovery in his conscious level, heparin was recommenced. Within three months of the initial presentation of visual disturbance he developed significant haematuria, with further evidence of disseminated intravascular coagulation (DIC). Over a period of one week the coagulopathy progressed. This failed to respond to treatment with platelets and fresh frozen plasma and he died peacefully.
Post-mortem examination showed the cause of death to be a pulmonary embolus, with a thrombosed right external iliac vein. There was a stage 4 bladder carcinoma, invading through the bladder wall into the perivesical fat, with a right hydronephrosis and hydroureter. Histology showed an ulcerated poorly differentiated transitional cell carcinoma extending into the perivesicular fat, and lymphatic channel invasion. There was no evidence of metastatic spread. On examining the brain, there were bilateral basal occipital infarcts and bilateral parietal infarcts, all being recent, with signs of colliquative necrosis. Additional infarcts were present in the kidney and spleen, with gangrenous infarction of the right forefoot and toes of the left foot. There was no evidence of an embolic source in the heart or great vessels.
Discussion
Cerebral achromatopsia has been recognised for many years, with debate over the existence of a specific cortical colour centre. Clinical evidence links the anterior inferior part of the occipital lobe with colour perception in man. Bilateral lesions at this site may cause achroma-topsia with preservation of primary visual function.9 A unilateral lesion will cause hemiachromatopsia. Animal studies, and more recently functional positron emission tomography studies in man,'0 have shown an area in the lingual and fusiform gyri ofman, equivalent to area V4 in the macaque monkey, which appears to function as a centre for colour vision.' More recently, further experimental evidence in the monkey has cast doubt on area V4 being the centre for cortical registration of colour. " Monkeys appear to show the opposite pattern of deficit to humans, with preserved colour discrimination, but impairment of shape discrimination.
Cerebral achromatopsia must be distinguished from other syndromes of impaired colour vision (see box). The description by the patient we report, of the world appearing to be in black and white ('as if watching a black and white television') is typical. The Farnsworth 100-Hue Test7'8 assesses the ordering of chromatically graded coloured discs, and is characteristically abnormal in achromatopsia. The assessment of central achromatopsia can be especially difficult when the deficit is limited to a quadrant or hemifield, as it may spare the regions near fixation. '2 Most cases of cerebral achromatopsia are due to cerebral infarction caused by cerebrovascular disease or embolic phenomena,9 and are bilateral, although some cases of homonymous hemiachromatopsia have been reported. '3-'8 Cerebral achromatopsia has also been reported as a rare manifestation of migraine. 9 Fine emboli occluding the penetrating branches of the calcarine artery at its termination will cause appropriate infarction, whilst larger emboli, and basilar artery occlusion, lead to preservation of the colour centre of the visual cortex as the blood supply is preserved by superficial branches of the posterior and middle cerebral arteries in this area.20 MR angiography would appear to be the investigation of choice.
The association of thrombosis and cancer is well recognised, although the precise mechanisms remain uncertain. Arnand Trousseau first Impaired colour vision * achromatopsia = cannot see colour * agnosia = loss of colour knowledge * anomia = inability to name colour described the association of a thrombotic state, especially a superficial migratory thrombophlebitis, with neoplasia in 1865. More recently it has been recognised that phlebitis is one ofmany manifestations ofthe coagulopathy associated with neoplasia.21 '22 The cause is likely to be multifactorial, including platelet activation by the tumour cells, procoagulant production by activated macrophages, and direct tumour cell procoagulant production.23
Thrombosis is found in around 150% of all cases of malignancy, especially pancreatic car- 24 cinoma.
Many patients with a chronic DIC will not show excessive bleeding, and diffuse thrombosis may be the only clinical manifestation. In chronic, or low grade, DIC associated with malignancy, many laboratory parameters of haemostasis may be within normal limits, or difficult to interpret.24 '25 The coagulopathy may resolve with treatment of the underlying cancer, especially prostatic carcinoma. Patients with cancer may be resistant to anticoagulant therapy, with thrombotic episodes continuing, but warfarin and heparin may have some benefit on both the laboratory measures of the coagulopathy, and the clinical features. The main problem, as in this patient, may be bleeding from the tumour, and also the risk of intracerebral haemorrhage with pre-existing cerebral lesions. Aspirin and dipyridamole have been suggested as an alternative for both prophylaxis of extension of thrombi, and longterm prophylactic therapy.24 Other manifestations of the thrombotic coagulopathy seen in this patient include infarction of the kidney and spleen, digital arterial thrombosis leading to gangrene, and deep vein thrombosis with pulmonary embolism.26
